Stocks · News reference
LENZ Therapeutics reported its third-quarter 2026 financial results and announced a strategic consumer marketing-focused reorganization alongside the transition of its CEO.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
LENZ Therapeutics (NASDAQ:LENZ) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga
Filed: 2026-10-28 AccNo: 0001815776-26-000056 Size: 304 KB Item 2.02: Results of Operations and Financial Condition Item 2.05: Cost Associated with Exit or Disposal Activities Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
LENZ Therapeutics, Inc. has announced it will host a webcast on October 29, 2026, to discuss its financial results for the third quarter of 2026.